Literature DB >> 8321846

Interferon-gamma in starch microparticles: nitric oxide-generating activity in vitro and antileishmanial effect in mice.

L Degling1, P Stjärnkvist, I Sjöholm.   

Abstract

Recombinant mouse interferon-gamma (mu IFN-gamma) was covalently coupled to polyacryl starch microparticles, a lysosomotropic drug carrier. The microparticle-bound mu IFN-gamma was found to activate cultured macrophages for nitrite production and had an anti-leishmanial effect in mice. Low doses of mu IFN-gamma, which had no effect in the free form, when bound to microparticles significantly reduced the load of Leishmania donovani in infected mice. Further, inducement of nitrite production in cultured macrophages by microparticle-bound mu IFN-gamma required intact cell membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321846     DOI: 10.1023/a:1018936522266

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

Review 1.  Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens.

Authors:  S J Green; C A Nacy; M S Meltzer
Journal:  J Leukoc Biol       Date:  1991-07       Impact factor: 4.962

2.  Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

Authors:  R Badaro; E Falcoff; F S Badaro; E M Carvalho; D Pedral-Sampaio; A Barral; J S Carvalho; M Barral-Netto; M Brandely; L Silva
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

3.  Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader.

Authors:  E Pick
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Antiviral and antiproliferative properties of liposome-associated human interferon-gamma.

Authors:  D M Smith; E Mayhew; R Reszka; M Ito; J A O'Malley
Journal:  J Interferon Res       Date:  1990-04

5.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

6.  Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo.

Authors:  S Hockertz; G Franke; E Kniep; M L Lohmann-Matthes
Journal:  J Interferon Res       Date:  1989-10

7.  Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes.

Authors:  S G Reed; M Barral-Netto; J A Inverso
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

Authors:  R Kurzrock; M G Rosenblum; S A Sherwin; A Rios; M Talpaz; J R Quesada; J U Gutterman
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

9.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate.

Authors:  A J Baillie; G H Coombs; T F Dolan; C A Hunter; T Laakso; I Sjöholm; P Stjärnkvist
Journal:  J Pharm Pharmacol       Date:  1987-10       Impact factor: 3.765

View more
  2 in total

1.  Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

Authors:  S Segura; C Gamazo; J M Irache; S Espuelas
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Preparation of bioactive interferon alpha-loaded polysaccharide nanoparticles using a new approach of temperature-induced water phase/water-phase emulsion.

Authors:  Guang Liu; Dong Xu; Mier Jiang; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2012-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.